Kursprognose für Immutep Ltd (IMMP)IMMPImmutep Ltd

Alphio's IMMP stock price prediction model matches the current Immutep Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.14 (-1.26%). The 1-week path is $3.17 (-0.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Immutep Ltd (IMMP) is a good buy right now due to its recent FDA Orphan Drug Designation for Eftilagimod Alfa, which significantly enhances its market potential. The current price of $3.18 is well below its 52-week high of $70.60, indicating substantial upside potential. Additionally, the stock has shown a recent positive momentum with a 5-day change of +3.92% and a remarkable 18.22% increase yesterday, signaling strong market interest. However, the stock is still down 94.61% year-to-date, highlighting the risks associated with its volatility and recent trial failures. The forward P/E ratio of 7.13 suggests that the stock may be undervalued relative to its future earnings potential, making it an attractive long-term investment despite the inherent risks.

Immutep Ltd (IMMP) last closed at $3.1800001, gaining +18.22%. These facts feed the 1-day and 1-week IMMP price prediction above.